Abstract: The present invention relates to long acting pharmaceutical compositions or pharmaceutically acceptable salts thereof, useful in the treatment or prevention of Human Immunodeficiency Virus (HIV) infections.
Type:
Application
Filed:
March 24, 2015
Publication date:
August 31, 2017
Applicant:
Glaxo Smith Kline Intellectual Property (No.) Limited